Full title: Nicrogacestat in premenopausal Females with Desmoid Tumour/Aggressive Fibromatosis (DT/AF)
Age: 18-40
Phase: 4
Locations:
- Cambridge – Cambridge University Hospitals NHS Foundation Trust
- London – University College London Hospital, The Royal Marsden NHS Foundation Trust
- Manchester – The Christie NHS Foundation Trust
Brief summary:
This study is looking at how the drug nicrogacestat affects ovarian function in women with progressing desmoid tumours/aggressive fibromatosis who are premenopausal.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
